MedTrace Logo

Biomagnetic Characterization of Gastric Dysrhythmias III

NCT03176927 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2026-04-22

No results posted yet for this study

Summary

There is a tremendous clinical need for a noninvasive technique that can assess gastric electrical activity and would be repeatable without any exposure to radiation. Investigators developed a new technique allowing to use noninvasive methods to assess bioelectrical activity in the gastrointestinal system. This has enabled to characterize the normal and pathologic physiology of the stomach through the use of noninvasive magnetogastrogram (MGG) records. Primary hypothesis for this proposal is that analysis of gastric slow wave uncoupling and propagation in multichannel MGG discriminates between normal and pathological gastric electrical activity. Eventually, investigators envision this research leading to new insights for gastrointestinal conditions such as gastroparesis, functional dyspepsia and chronic idiopathic nausea that would inform clinical management of these debilitating diseases.

Conditions

  • Diabetics Without Symptoms of Gastroparesis
  • Diabetic Gastroparesis
  • Idiopathic Gastroparesis
  • Total or Partial Gastrectomy
  • Chronic Nausea
  • Functional Dyspepsia

Interventions

DIAGNOSTIC_TEST

magnetogastrogram

Sponsors & Collaborators

Principal Investigators

  • Leonard A Bradshaw, PhD · Vanderbilt University Medical Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-12-28
Primary Completion
2021-05-19
Completion
2021-05-19

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03176927 on ClinicalTrials.gov